vitamin D administration on chronic liver disease

Not Applicable

Recruiting

• Conditions: chronic liver disease; chronic liver disease , vitamin D; D006521

• Registration Number: JPRN-jRCTs031200015
• Lead Sponsor: Okubo Tomomi

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-04-15
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

Patients with chronic liver disease
20 years old or older, under 85 years old
Both hospitalization / outpatient
Patients with serum 25 (OH) D3 concentration deficiency less than 20 ng / ml

Exclusion Criteria

Hepatic encephalopathy more than 3
Total bilirubin value >3 mg/dl
Patien with decrease of the protein composition ability in the liver
The patient allergic to milk
The patient who is nursing and pregnant
Patient with uncotrolled HCC or other malignant tumor
Uncontrolled heart failure patient
Uncontrolled hypertension or diabetes
Patient with Chronic renal failure
Patient of hypercalcemia
Patient with hyperthyroidism
Patient who already takes other vitamin D
Patien who takes the drug that combination with the vitamin D preparation is contraindicated
Patient with acute liver failure
Patient who were judged unsuitable by test responsibility doctor

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Skeletal muscle mass, grip, Liver fibrosis